Evidence map›Paper›PMID 14962388›Full record

ArticleStructure (London, England : 1993)2004

Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex.

Yiwei Zhao, Zhong Li, Sandra J Drozd, Yi Guo, Walid Mourad, Hongmin Li

Abstract read
In one paragraph

Article in Structure (London, England : 1993), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Cisplatin protects mice from challenge ofEmerging microbes & infections · 2019
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A single point mutation changes the crystallization behavior of Mycoplasma arthritidis-derived mitogen.Acta crystallographica. Section F, Structural biology and crystallization communications · 2006
    Article
  13. Expression, purification and crystallization of Streptococcus dysgalactiae-derived mitogen.Acta crystallographica. Section F, Structural biology and crystallization communications · 2006
    Article
  14. Crystal structures of T cell receptor (beta) chains related to rheumatoid arthritis.Protein science : a publication of the Protein Society · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiwei ZhaoWadsworth Center, New York State Department of Health, Empire State Plaza, PO Box 509, Albany, NY 12201, USA.
Zhong Li
Sandra J Drozd
Yi Guo
Walid Mourad
Hongmin Li

Funding

Superantigen-immunoreceptor interactionsR01AI050628 · NIAID · WADSWORTH CENTER · PI LI, HONGMIN · 2002 to 2004
$864k
NIAID NIH HHS AI50628NIAID NIH HHS R01 AI050628
6 · The paper itself

Abstract

Mycoplasma arthritidis-derived mitogen (MAM) is a superantigen that can activate large fractions of T cells bearing particular TCR Vbeta elements. Here we report the crystal structure of MAM complexed with a major histocompatibility complex (MHC) antigen, HLA-DR1, loaded with haemagglutinin peptide 306-318 (HA). The structure reveals that MAM has a novel fold composed of two alpha-helical domains. This fold is entirely different from that of the pyrogenic superantigens, consisting of a beta-grasped motif and a beta barrel. In the complex, the N-terminal domain of MAM binds orthogonally to the MHC alpha1 domain and the bound HA peptide, and to a lesser extent to the MHC beta1 domain. Two MAM molecules form an asymmetric dimer and cross-link two MHC antigens to form a plausible, dimerized MAM-MHC complex. These data provide the first crystallographic evidence that superantigens can dimerize MHC molecules. Based on our structure, a model of the TCR2MAM2MHC2 complex is proposed.

Indexed as

Models, MolecularProtein FoldingAntigensAntigens, BacterialCrystallography, X-RayDimerizationHLA-DR1 AntigenMajor Histocompatibility ComplexMitogensMycoplasma arthritidisProteinsProtein Structure, TertiarySuperantigensAntigensAntigens, BacterialHLA-DR1 AntigenMitogensMycoplasma arthritidis mitogenProteinsSuperantigens

Identifiers

PMID14962388
PMCPMC3923524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.